Cervical cancer is the second most common cancer to affect women aged 15–44 years in the EU. Vaccination is highly effective in protecting against HPV, which is responsible for the vast majority of cervical cancers.
Sharp increase in flu and RSV virus activity in the EU/EEA
There has been a sharp increase in indicators for both influenza and respiratory syncytial virus (RSV) activity in almost all countries reporting to ECDC, with a tangible impact in secondary care.
Reducing antimicrobial resistance: accelerated efforts are needed to meet the EU targets
Data published by ECDC in connection with European Antibiotic Awareness Day shows that, despite improvement in some areas, the EU is lapsing in progress towards its 2030 antimicrobial resistance (AMR) targets.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11 – 17 January 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, mpox, influenza, cholera, Marburg virus, rabies, and chikungunya, measles, polio, MRSA, and mass gathering monitoring for the Jubilee of 2025 in Italy.
In 2022, 17 700 confirmed cases of invasive pneumococcal disease (IPD) were reported in the European Union/European Economic Area. The crude notification rate was 5.1 cases per 100 000 population, similar to 2018 and 2019.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 - 10 January 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, measles, mpox clades I and II, Middle East respiratory syndrome coronavirus (MERS-CoV), respiratory viral infections in China, and avian influenza A(H5N1).
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.